Health officials have given a life-extending drug the green light for widespread NHS, giving hope to thousands of men facing a "death sentence" from prostate cancer.
The National Institute for Health and Care Excellence (Nice) said the drug enzalutamide, also known as xtandi, should be considered for use in the treatment of men with hormone relapsed prostate cancer that has spread to other parts of the body.
Nice said in its draft guidance that it was pleased to recommend the drug, which is manufactured by Astellas Pharma, for patients who have few other treatment options left.
More top news
The drinks manufacturer said it would be transferring production of Robinsons and Fruit Shoot from Carrow Works to other locations.
Most places will be dry with sunny spells, after a frosty, locally icy start.
Toronto police said they were investigating the deaths of Barry Sherman and his wife who were found at their mansion.